论文部分内容阅读
近年来,急性白血病患者出血并发症的主要原因——纤维蛋白溶解的激活,已引起众多学者的关注。本文研究了40例(男22,女18)各种类型白血病患者,其中早幼粒细胞型2例,原淋巴细胞型11例,原粒细胞型7例,原单核细胞型7例,粒单细胞型4例,红白血病1例,低增生型1例,未分化细胞型7例。患者年龄在15-70岁之间。共进行了64次纤维蛋白溶解系统的综合检查,其中36次是在出血时期检查的,14例出血症状非常显著(广泛皮下溢血、淤斑、多部位大量出血),3例出现了血栓(2例下肢血栓性静脉炎,1例小腿深部静脉血栓和肺动脉栓塞)。通常,急性白血病患者可见纤维蛋白溶解系统激活。对上述患者检测后发现,血浆总纤维蛋白的溶解
In recent years, the main cause of hemorrhagic complications in patients with acute leukemia - fibrinolytic activation has attracted the attention of many scholars. In this study, 40 cases (male 22, female 18) of various types of leukemia patients, including 2 cases of promyelocytic type, 11 cases of primitive lymphocyte type, 7 cases of primitive myeloid, 7 cases of primitive monocytic, 4 cases of cell type, 1 case of erythroleukemia, 1 case of low-proliferation, 7 cases of undifferentiated cell type. Patients aged 15-70 years old. A total of 64 fibrinolytic system tests were performed, of which 36 were examined at the bleeding stage, 14 had significant bleeding symptoms (extensive subcutaneous haemorrhage, ecchymosis, massive bleeding in multiple sites) and thrombosis in 3 (2 Cases of lower extremity thrombophlebitis, 1 case of deep vein thrombosis and pulmonary embolism. In general, fibrinogen activation is seen in patients with acute leukemia. On the detection of these patients found that the dissolution of plasma total fibrin